Latest Interviews
Showing 1–2 of 2 transcripts.
Clear all filters- Milken Institute1h 2m
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
Esther Krofah, Francis Collins, Richard Moscicki, Ellen Sigal, Janet Woodcock
Hosted by Faster Cures, a webinar convened NIH officials and industry leaders to analyze the COVID-19 pandemic's acceleration of biomedical innovation, highlighting achievements such as the ACTIV partnership's master protocols and the RADx initiative's diagnostic scaling. The discussion detailed how the crisis forced a shift toward competitive collaboration, decentralized trials, and the successful achievement of diverse vaccine trial enrollment, while simultaneously exposing critical infrastructure gaps in clinical trial execution and real-world data integration. Panelists concluded with a consensus that emergency-driven reforms must be institutionalized through permanent policy changes and public-private partnerships to sustain preparedness for future health threats.
- Milken Institute1h 0m
In Search for a Cure: Are We Nearing a Treatment for COVID-19?
Dr Anthony Fauci, Albert Bourla, Esther Krofah, Meg Tirrell
Dr. Anthony Fauci and Pfizer executives outlined the current U.S. pandemic crisis, characterized by rising infections among young demographics and projected second-wave risks in the fall due to premature reopening and asymptomatic spread. While addressing safety protocols like sample pooling for testing and the inclusion of vulnerable populations in trials, Pfizer anticipates initiating Phase 3 trials in July with a potential vaccine rollout by late 2020 or early 2021. Simultaneously, clinical guidelines have been updated to include dexamethasone for severe cases, though experts emphasize that continued public health measures remain essential until herd immunity is achieved.